| HIV Infection |
1 |
1 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.6 |
| Gonorrhea |
0 |
0.47 |
| Preexposure HIV Prophylaxis |
0 |
0.99 |
| AIDS |
0 |
0.35 |
| Clinical Guidelines |
0 |
0.35 |
| Hospital |
0 |
0.35 |
| Prophylaxis |
0 |
0.35 |
| Revenue and Practice Management |
0 |
0.28 |
| Social Determinants of Health |
0 |
0.28 |
| Syphilis |
0 |
0.26 |
| Antibiotic Resistance |
0 |
0.23 |
| CT Scan |
0 |
0.23 |
| Antibiotics |
0 |
0.18 |
| Allergy |
0 |
0.12 |
| Bacteria |
0 |
0.12 |
| Board Certification |
0 |
0.12 |
| California |
0 |
0.12 |
| Chlamydial Infection |
0 |
0.12 |
| Drug Resistance |
0 |
0.12 |
| Grant |
0 |
0.12 |
| International Practice of Medicine |
0 |
0.12 |
| Outpatient Clinic |
0 |
0.12 |
| Sexual Health |
0 |
0.12 |
| Sexually Transmitted Infection |
0 |
0.12 |
| Staphylococcus Aureus Infection |
0 |
0.12 |
| Transgender |
0 |
0.12 |
| Washington |
0 |
0.12 |
| Health Care Reform |
0 |
0.09 |
| Staphylococcal Infection |
0 |
0.09 |